Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Sébastien Gaujoux

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1072-7639; OpenAlex author ID A5072348796. Sources: OpenAlex.

Their work

Papers
17 (first author 2, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
76
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: 5 papers · 2020: none · 2021: 3 papers · 2022: none · 2023: none · 2024: 3 papers · 2025: 2 papers

Papers 17

  1. Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PROD… Last author DOI 10.1200/jco-24-01378↗
  2. Prognosis Associated with Complete Pathological Response Following Neoadjuvant Treatment for PancreaTic AdenOcarciNOma in the FOFLIRINOX Era: the Multicenter T… Co-author DOI 10.1245/s10434-024-16735-2↗
  3. Management of malignant Gastric Outlet Obstruction (mGOO) due to pancreatic cancer in the era of EUS-Gastrojejunostomy: an international practice survey and ca… Co-author DOI 10.1007/s00464-024-10803-0↗
  4. Should liver metastases of pancreatic adenocarcinoma be resected? Last author DOI 10.1016/j.jviscsurg.2023.12.006↗
  5. Splenic vein tumor thrombosis is a major prognostic factor in distal pancreatic adenocarcinoma. Last author DOI 10.1016/j.surg.2023.10.028↗
  6. A Novel Pancreatic Fistula Risk Score Including Preoperative Radiation Therapy in Pancreatic Cancer Patients. Co-author DOI 10.1007/s11605-020-04600-y↗
  7. Distal Pancreatectomy with Celiac Axis Resection-with Posterior Ramps Approach-for Locally Advanced Pancreatic Adenocarcinoma with Celiac Trunk Infiltration (M… Last author DOI 10.1007/s11605-020-04782-5↗
  8. The role of radiotherapy in locally advanced pancreatic cancer. Co-author DOI 10.1259/bjr.20210044↗
  9. Characteristic and outcomes of patients with pathologic complete response after preoperative treatment in borderline and locally advanced pancreatic adenocarci… Co-author DOI 10.1016/j.clinre.2019.03.007↗
  10. Pancreatic cancer is still waiting for the big leap forward. Co-author DOI 10.1016/j.lpm.2019.02.013↗
  11. Pancreatic cancer surgical management. Last author DOI 10.1016/j.lpm.2019.02.027↗
  12. McCune Albright syndrome is a genetic predisposition to intraductal papillary and mucinous neoplasms of the pancreas associated pancreatic cancer in relation w… Co-author DOI 10.1097/md.0000000000018102↗
  13. Risk and Predictors of Postoperative Morbidity and Mortality After Pancreaticoduodenectomy for Pancreatic Neuroendocrine Neoplasms: A Comparative Study With Pa… Co-author DOI 10.1097/mpa.0000000000001273↗
  14. Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC). First author DOI 10.1016/j.dld.2018.08.008↗
  15. Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review. Co-author DOI 10.1016/j.pan.2014.11.006↗
  16. Does pre-operative chemoradiation for initially unresectable or borderline resectable pancreatic adenocarcinoma increase post-operative morbidity? A case-match… First author DOI 10.1111/hpb.12033↗
  17. Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Co-author DOI 10.1245/s10434-012-2301-y↗

Closest collaborators

The 25 strongest of 76 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Alain Sauvanet · 6 shared papers, 2019–2025 · strength 0.89
  2. Jean‐Baptiste Bachet · 5 shared papers, 2018–2024 · strength 0.75
  3. Milena Muzzolini · 2 shared papers, 2024–2025 · strength 0.41
  4. Charles de Ponthaud · 2 shared papers, 2024–2025 · strength 0.39
  5. Ugo Marchèse · 2 shared papers, 2024–2025 · strength 0.34
  6. António Sá Cunha · 3 shared papers, 2018–2024 · strength 0.32
  7. Florence Jeune · 2 shared papers, 2019–2024 · strength 0.29
  8. F. Huguet · 3 shared papers, 2013–2021 · strength 0.27
  9. Renato Micelli Lupinacci · 1 shared paper, 2024 · strength 0.26
  10. Giacomo Emanuele Maria Rizzo · 1 shared paper, 2024 · strength 0.23
  11. Stuart Michael Robinson · 1 shared paper, 2024 · strength 0.23
  12. Gabriele Capurso · 1 shared paper, 2024 · strength 0.23
  13. Giuseppe Vanella · 1 shared paper, 2024 · strength 0.23
  14. Jade Fawaz · 1 shared paper, 2021 · strength 0.22
  15. Maxime Barat · 1 shared paper, 2021 · strength 0.22
  16. Frédéric Prat · 2 shared papers, 2019 · strength 0.21
  17. Romain Coriat · 2 shared papers, 2019 · strength 0.21
  18. Jacques Belghiti · 1 shared paper, 2019 · strength 0.20
  19. Patrick Pessaux · 1 shared paper, 2024 · strength 0.18
  20. Gerlinde Avérous · 1 shared paper, 2024 · strength 0.18
  21. Mathilde Wagner · 1 shared paper, 2024 · strength 0.18
  22. Lilian Schwartz · 1 shared paper, 2025 · strength 0.16
  23. Julie Navez · 1 shared paper, 2025 · strength 0.16
  24. Jonathan Garnier · 1 shared paper, 2025 · strength 0.16
  25. Mehdi El Amrani · 1 shared paper, 2025 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.